Equine alpha-fetoprotein levels in Lipizzaner mares with normal pregnancies and with pregnancy loss.

The study investigates whether equine alpha-fetoprotein (eqAFP), a molecule that is shown to be an important indicator of fetal health in humans, can be used as a similar measure in Lipizzaner horses. The results suggest that there is a notable difference in eqAFP levels during normal and complicated pregnancies, thereby highlighting its potential as a diagnostic tool for evaluating fetal well-being in horses.

Research Methodology

• The research analyzes the levels of eqAFP in serum samples taken from 30 Lipizzaner mares during various stages of pregnancy, ranging from Days 60 to 325.
• Of these mares, 23 had a normal pregnancy, six experienced late embryonic loss, and one miscarried in the ninth month of gestation.

Findings

• Equine alpha-fetoprotein concentrations were observed to be significantly different in normal pregnancies (72.93 ± 49.25 pg/mL; mean ± standard deviation) as against those with complications leading to pregnancy loss (152 ± 36.48 pg/mL; mean ± standard deviation).
• Factors such as the age of the mares, the stage of pregnancy, and the conception rate significantly influenced the alpha-fetoprotein concentrations in the normal group.
• The study also observed notable differences in eqAFP concentrations from one mare to another.

Implications and Future Research

• While eqAFP seems to be a key indicator of fetal well-being in horses, similar to its role in human pregnancies, further research is needed to address unanswered questions like the fluctuations in eqAFP levels in foals of different age groups, ponies, and draft horses.
• The researchers assert that large-scale studies should be conducted to validate the specificity, sensitivity, and reliability of eqAFP concentrations as a diagnostic tool to evaluate fetal health in horses.